Stein Kvaløy

Title: Stein Kvaløy: Innovator in Lymphoma Research

Introduction

Stein Kvaløy is a notable inventor based in Oslo, Norway, recognized for his contributions to the field of lymphoma research. He holds two patents that focus on improving the diagnosis and treatment of diffuse large B cell lymphoma (DLBCL). His work has significant implications for patient care and therapeutic strategies.

Latest Patents

Kvaløy's latest patents include a survival predictor for diffuse large B cell lymphoma. This invention provides methods and materials related to a gene expression-based survival predictor for DLBCL patients. Additionally, he has developed methods for identifying, diagnosing, and predicting survival of lymphomas. His inventions utilize gene expression data to enhance the accuracy of identifying and diagnosing lymphoproliferative disorders. The present invention discloses a novel microarray, the Lymph Dx microarray, which is designed to obtain gene expression data from lymphoma samples. This information is crucial for determining the identity of a particular lymphoma and predicting survival in diagnosed subjects.

Career Highlights

Throughout his career, Kvaløy has worked with esteemed organizations, including the Government of the United States of America as represented by the Secretary of the Department of Health and Human Services and the University of Nebraska. His innovative research has contributed to advancements in the understanding and treatment of lymphomas.

Collaborations

Kvaløy has collaborated with prominent figures in the field, including Wyndham H. Wilson and Richard I. Fisher. These partnerships have furthered the impact of his research and inventions.

Conclusion

Stein Kvaløy's work in lymphoma research exemplifies the importance of innovation in medical science. His patents and collaborations have the potential to significantly improve patient outcomes in the treatment of lymphoproliferative disorders.